Massachusetts attorney Thomas M. Kiley concentrates on legal issues regarding defective products. A recent article in the Washington Post indicates that the Federal Food and Drug Administration (FDA) announced that India’s largest drugmaker has falsified laboratory tests for generic drugs that were approved for sale in the US.
According to the article the FDA identified problems at the Ranbaxy Laboratories plant in Paonta Sahib where evidence shows they falsified data and test results in approved and pending drug applications for 25 drugs that were approved by the FDA. They don’t believe any of those medications are on the shelves of any US pharmacies because Ranbaxy has been prevented from exporting more than two dozen drugs in the US.
